BlueWind Initiates U.S. Enrollment in Clinical Trial of the RENOVA iStim to Treat Overactive Bladder
PARK CITY, Utah and HERZLIYA, Israel, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BlueWind Medical announced today that enrollment has commenced at U.S. sites in the Pivotal Clinical Trial of the RENOVA iStim™ ...
TAMPA, Fla., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Overactive bladder or OAB, affects millions of women of all ages, and can negatively impact nearly every aspect of daily life—from work performance to ...
Effective, patient-centric treatment for overactive bladder seems to be on the horizon in the form of Bluewind Medical’s new device, the RENOVA iStim system. Looking to rewrite the rules for the way ...
Results from 36-month OPTIMIST Follow-Up study show BlueWind Renova™ is a safe, minimally invasive system that offers durable and significant improvements for Over Active Bladder patients HERZLIYA, ...
Results from 6-Month OPTIMIST Study show BlueWind Renova™ is a safe, minimally invasive system that offers significant improvements for Over Active Bladder patients. BlueWind Medical, developer of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results